Eagle Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,427,922
| Closed | -$16.5M | – | 651 |
|
|
2017
Q4 | $16.5M | Sell |
1,427,922
-3,145
| -0.2% | -$36.3K | 0.09% | 257 |
|
|
2017
Q3 | $17.6M | Sell |
1,431,067
-325,440
| -19% | -$4M | 0.1% | 270 |
|
|
2017
Q2 | $20.1M | Buy |
1,756,507
+601,242
| +52% | +$6.88M | 0.12% | 237 |
|
|
2017
Q1 | $24M | Buy |
1,155,265
+35,726
| +3% | +$743K | 0.15% | 199 |
|
|
2016
Q4 | $23.3M | Buy |
1,119,539
+5,001
| +0.4% | +$104K | 0.15% | 196 |
|
|
2016
Q3 | $36.5M | Sell |
1,114,538
-5,078
| -0.5% | -$166K | 0.25% | 124 |
|
|
2016
Q2 | $28M | Sell |
1,119,616
-23,477
| -2% | -$586K | 0.19% | 158 |
|
|
2016
Q1 | $28M | Sell |
1,143,093
-53,412
| -4% | -$1.31M | 0.19% | 165 |
|
|
2015
Q4 | $39.5M | Buy |
1,196,505
+36,274
| +3% | +$1.2M | 0.26% | 133 |
|
|
2015
Q3 | $38M | Sell |
1,160,231
-226,739
| -16% | -$7.43M | 0.26% | 131 |
|
|
2015
Q2 | $73.5M | Buy |
1,386,970
+259,737
| +23% | +$13.8M | 0.41% | 80 |
|
|
2015
Q1 | $32.5M | Buy |
+1,127,233
| New | +$32.5M | 0.19% | 169 |
|